P-12, r. 6.1 - Regulation respecting medications that a podiatrist may administer or prescribe

Updated to 1 May 2020

This document has official status.

chapter P-12, r. 6.1

Regulation respecting medications that a podiatrist may administer or prescribe

Podiatry Act

(chapter P-12, s. 12).

1. A podiatrist who obtained a permit to practise on or after 1 January 1976 may, in the practice of the profession, administer or prescribe the medications listed in the Schedule.

Despite the foregoing, where a podiatrist referred to in the first paragraph obtained a permit to practise before 1 May 2020, the podiatrist must, to administer or prescribe medications, have completed the training of at least 12 hours recognized by the Ordre des podiatres du Québec on good practices in the administration and prescription of medications.

O.C. 172-2020, s. 1.

2. (Omitted).

O.C. 172-2020, s. 2.

SCHEDULE

(s. 1)

NOTE: The following classification refers to the classification prepared by the American Hospital Formulary Service.

1. Every medication belonging to the following classification, subject to the restrictions indicated:

Therapeutic classes	Therapeutic subclasses	Therapeutic sub‑subclasses	Restrictions
Antihistamines	First generation antihistamines
	Second generation antihistamines
Anti-infective agents	Anthelminthics
	Antibacterial agents
	Antifungals
	Antimycobacterial agents
	Antivirals
	Other anti-infective agents
Antineoplastic agents
Autonomic drugs	Sympathomimetic agents	Alpha and beta adrenergic agonists
	Squeletal muscle relaxants	Centrally acting muscle relaxants
Central nervous system drugs	Analgesics and antipyretics	Non-steroid anti-inflammatories
		Opiate antagonist	Quantity limited to 3 days
		Various analgesics and antipyretics
	Narcotic antidotes
	Anxiolytics, sedatives and hypnotics	Benzodiazepines	Quantity limited to 4 doses
		Various anxiolytics, sedatives and hypnotics	Quantity limited to 4 doses
Eye, ear, nose and throat (EENT) preparations	E.E.N.T. anti-infective agents	Antibiotics
Gastrointestinal drugs	Antiulcer agents and anticids	Prostaglandins	For the duration of the non-steroid anti-inflammatory therapy
		Proton pump inhibitor	For the duration of the non-steroid anti-inflammatory therapy
Hormones and substitutes	Corticosteroids
Local anasthetics
Skin and mucous membranes	Anti-infective agents	Antibacterial agents
		Antifungals
		Other local anti-infective agents
	Anti-inflammatories
	Antipruritics and local anesthetics
	Protective agents – emollients – oils
	Keratolytic agents
	Keratoplastic agents
	Skin and mucous membranes, various
Other medications		Various others

2. Any other medication intended for topical, injectable or oral administration that is not listed in Schedule I to the Regulation respecting the terms and conditions for the sale of medications (chapter P-10, r. 12).

3. Any combination of medications of this Schedule, subject to applicable restrictions.

4. Any product for an extemporaneous mixture and any vehicle, solvent or adjuvant.

O.C. 172-2020, Sch.

REFERENCES

O.C. 172-2020, 2020 G.O. 2, 773